| Financial Year |
March 31 2023 |
| Monetary Funds |
271,540,203.68 |
| Held-for-trading Financial Assets |
391,380.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
90,597,602.39 |
| Advances to Suppliers |
3,395,647.86 |
| Other Receivables |
2,510,253.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
154,707,729.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,276,789.42 |
| Total Current Assets |
529,898,647.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,404,208.20 |
| Investment Properties |
18,351,939.03 |
| Fixed Assetes |
92,099,064.34 |
| Under-construction Projects |
40,890,617.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,610,237.40 |
| R&D expenses |
-- |
| Goodwill |
14,583,223.53 |
| Long-Term Deferred and Prepaid Expenses |
4,636,581.45 |
| Deferred Income Tax Assets |
18,812,274.62 |
| Other Non-Current Assets |
2,387,362.35 |
| Sub-Total of Non-Current Assets |
268,362,139.83 |
| Total Assets |
798,260,787.16 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,000,000.00 |
| Accounts Payable |
75,717,454.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,918,138.27 |
| Taxes Payable |
9,447,209.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,966,245.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,369,020.19 |
| Other Current Liabilities |
1,323,568.30 |
| Sub-Total of Current Liabilities |
136,142,327.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,100,587.57 |
| Deferred Income Tax Liabilities |
686,127.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,280,794.54 |
| Total Liabilities |
153,423,121.72 |
| Paid-In Capital(Or Share Stock) |
188,352,192.00 |
| Capital Surplus |
203,784,364.65 |
| Surplus Reserve |
26,725,439.09 |
| LESS:Treasury Stock |
12,038,339.00 |
| Undistributed Profits |
231,691,541.76 |
| Minority Stockholder's Interest |
6,322,466.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
638,515,198.50 |
| Owner's Equity（Stockholder's Equity） |
644,837,665.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
798,260,787.16 |
